Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery

Inclusion Criteria: * Elected to undergo surgery for recent diagnosis of parotid or submandibular gland tumor * Ability to adhere to study visit schedule and other protocol requirements * Operable candidate base on the surgeon's note * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Nursing or pregnant * Diagnosis of kidney disease, history of renal disease with creatinine \> 1.5 mg/dL, or currently on dialysis * Diagnosis of end stage liver disease * Any unstable medical condition * Use of chemotherapy or radiotherapy within 4 weeks before first dose of study dietary supplement * Unwilling to stop dietary supplements 3 weeks before first dose of study dietary supplement